Click 
to remove filters
Japanese pharmaceutical firm Yamanouchi has appointed Greenlines Healthcare Communications on fees in excess of pounds 200,000 to raise awareness of benign prostate hypertrophy, a urinary condition which affects men.
The healthcare PR sector in the UK had an active year during 1998. As the PR Week league table shows, there was plenty of movement in fee income among the leading healthcare consultancies.
Glaxo Wellcome will hear pitches at the end of this year for an account to mount the PR launch of its first smoking cessation product, Zyban.
Top ten pharmaceutical firm Eli Lilly, which produces the world s best selling anti-depressant, Prozac, has promoted Stephen Whitehead to the position of corporate affairs director for Europe.
Liberal Democrat health policy researcher and analyst Andrew Tucker has left the party to join GJW, where he is creating a new policy unit within the agency s health practice.
It is hardly surprising the BioIndustry Association s code of best practice, published for consultation last week, has been welcomed by PR professionals both in agencies and in-house.
Guidelines on communication between biotech companies and their investors, intended to prevent scandals such as the British Biotech affair last year, have been welcomed by PR specialists in the sector.
Unilever government relations head Cliff Grantham has been promoted to the post of UK communications and public affairs head with a brief to expand his department.
Gillette Group UK has hired Hill and Knowlton to handle the product PR launch for a hi-tech toothbrush from the UK s biggest-selling toothbrush brand, Oral-B.
Medecins Sans Frontieres executive director Anne-Marie Huby this week warned companies against token corporate citizenship activity which could result in negative PR.
